Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Restricted genetic defects underlie human complement C6 deficiency.

M A Dragon-Durey1, V Fremeaux-Bacchi, J Blouin

  • 1Département d'Immunologie, Hôpital Européen Georges Pompidou, INSERM U430, France.

Clinical and Experimental Immunology
|March 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs).

Oncoimmunology·2023
Same author

Online corrective responses following target jump in altered gravitoinertial force field point to nested feedforward and feedback control.

Journal of neurophysiology·2020
Same author

Double-Step Paradigm in Microgravity: Preservation of Sensorimotor Flexibility in Altered Gravitational Force Field.

Frontiers in physiology·2020
Same author

Cobalamin c deficiency associated with antifactor h antibody-associated hemolytic uremic syndrome in a young adult.

BMC nephrology·2020
Same author

Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2019
Same author

The role of complement inhibition in kidney transplantation.

British medical bulletin·2017
Same journal

Could we discuss the molecular signature of immune dysregulation?

Clinical and experimental immunology·2026
Same journal

The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

Clinical and experimental immunology·2026
Same journal

PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

Clinical and experimental immunology·2026
Same journal

Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

Clinical and experimental immunology·2026
Same journal

Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

Clinical and experimental immunology·2026
Same journal

Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.

Clinical and experimental immunology·2026
See all related articles

Complement C6 deficiency (C6D) is rare in Caucasians but more common in individuals of African descent. This study identifies specific genetic defects in the C6 gene responsible for C6D in individuals from Africa living in France.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Complement C6 homozygous deficiency (C6D) is infrequently observed in Caucasian populations.
  • C6D exhibits a higher prevalence among African-Americans, suggesting specific genetic underpinnings.
  • The clinical manifestations of C6D can include Neisseria meningitidis infections and autoimmune conditions.

Purpose of the Study:

  • To investigate the molecular basis of C6D in individuals of African descent living in France.
  • To identify specific genetic mutations within the C6 gene responsible for C6D.
  • To correlate genetic findings with clinical presentations in affected individuals.

Main Methods:

  • Genomic DNA analysis of seven unrelated black individuals with C6D.
  • Direct polymerase chain reaction (PCR) amplification of exons 6, 7, and 12 of the C6 gene.

Related Experiment Videos

  • Nucleotide sequencing of amplified DNA fragments to identify mutations.

    • Main Results:

    • Three patients were found to have a homozygous single-base deletion (1936delG) in exon 12.
    • Four patients presented compound heterozygous deletions, involving exon 7 (1195delC) or exon 6 (878delA) in conjunction with the exon 12 deletion (1936delG).
    • All patients exhibited undetectable levels of antigenic C6.

    Conclusions:

    • The study confirms a restricted pattern of genetic defects associated with homozygous C6 deficiency in individuals of African descent.
    • Specific mutations in exons 6, 7, and 12 of the C6 gene are identified as the cause of C6D in this population.
    • These findings contribute to understanding the genetic epidemiology of complement deficiencies.